Investment Rating - The report indicates a positive investment rating for the home cleaning and health supplement sectors, highlighting strong growth potential in proprietary brands and market expansion opportunities [4][9]. Core Insights - The report emphasizes the rapid growth of proprietary brands in home cleaning and health supplements, with a focus on expanding brand matrices and capturing market share [4][9]. - The home cleaning market in China exceeds 150 billion yuan, with fabric care being the largest category, driven by rising quality demands and emotional consumption trends [16][21]. - The dietary supplement market is projected to grow significantly, driven by increasing health awareness, an aging population, and the penetration of Generation Z consumers [34][35]. Summary by Sections Company Overview - The company has transitioned from an operational agency to a leading player in high-end home cleaning and health supplement proprietary brands, with a focus on brand management and operational efficiency [4][5]. Business Structure - The business model consists of three main segments: operational agency, brand management, and proprietary brands, with a notable increase in the share of proprietary brands [7][9]. Financial Performance - Revenue from proprietary brands reached 5.01 billion yuan in 2024, accounting for 28.37% of total revenue, with a gross margin of 66.92% [8][10]. - The company has seen significant revenue growth in its proprietary brands, with notable increases in sales for brands like VitaOcean and NUIBAY [11][12]. Industry Trends - The home cleaning industry is experiencing a shift towards premiumization, with consumers willing to pay a premium for quality and fragrance [21][30]. - The dietary supplement market is rapidly evolving, with a focus on beauty-related supplements and innovative functional ingredients gaining traction [34][38]. Market Dynamics - The report highlights the increasing online penetration of sales channels, particularly through content-driven e-commerce platforms like Douyin [24][26]. - The competitive landscape shows stable market shares among leading brands, with opportunities for new entrants in high-end segments [28][32].

Group 1 - The core point of the article is the decision made by the Board of Directors of Dong'e Ejiao Co., Ltd. to invest 1.485 billion yuan in the construction of a health consumer goods industrial park to support the high-quality development of its health consumer goods business [7][16][22] Group 2 - The Board of Directors meeting was held on February 9, 2026, with all 9 directors present, and the meeting complied with relevant laws and regulations [2][4][5] - The meeting approved several proposals, including adjustments to the members of the Board's specialized committees and the investment project for the health consumer goods industrial park [6][7][10] Group 3 - The investment project will utilize 1.485 billion yuan of the company's own funds, with 1.421 billion yuan allocated for fixed asset investment and 0.64 billion yuan for working capital [16][19] - The project aims to produce health consumer goods such as food and health supplements, and will include facilities for production, warehousing, quality inspection, and e-commerce [18][21] Group 4 - The construction of the industrial park is expected to take approximately 22 months from the start of construction [18] - The investment aligns with the company's "1238" development strategy, which focuses on high-quality development in traditional Chinese medicine and expanding into health consumer goods [21][22] Group 5 - The project is deemed necessary to meet the growing demand for health consumer products and to overcome current production capacity limitations [21][22] - The investment is expected to enhance the company's competitive advantage and support sustainable development without affecting existing business operations [22]

Core Viewpoint - Dong'e Ejiao has announced a significant investment of 1.485 billion yuan to build a health consumer goods industrial park in Shandong Province, marking one of its largest single investments in recent years and a key step in its "pharmaceutical + health consumer goods" dual-drive strategy [2][5]. Investment Details - The project will cover an area of 406,800 square meters, with a construction area of 151,100 square meters [6]. - Out of the total investment of 1.485 billion yuan, 1.421 billion yuan will be allocated to fixed asset investment, while 64 million yuan will be for working capital. The funding will come entirely from the company's own resources, with a construction period of 22 months [8]. Strategic Focus - The new industrial park aims to produce health consumer goods such as medicinal food, health supplements, and functional foods, including products like Ejiao cake, Ejiao dates, and Ejiao powder. It will also feature a comprehensive warehouse and e-commerce center, along with a quality inspection incubation center [8]. - The company has reported a revenue of 4.766 billion yuan for the first three quarters of 2025, a year-on-year increase of 4.41%, and a net profit of 1.274 billion yuan, up 10.53% year-on-year. As of the end of the third quarter of 2025, the company had cash reserves of 5.562 billion yuan [8]. Market Challenges - The company faces significant challenges related to the scarcity of its core raw material, donkey hide, which is crucial for its products. The decreasing availability of this resource poses a risk to the company's growth and expansion plans [9]. - To address this "raw material anxiety," the company is focusing on increasing the utilization and added value of its raw materials by extending into health consumer goods. This strategy includes developing deep-processed products that reduce reliance on single raw materials and enhance overall profit margins [10]. Competitive Landscape - The health consumer goods market is highly competitive, with many established players, making it more complex than the traditional pharmaceutical market where Dong'e Ejiao holds a dominant position. The company recognizes the importance of channel development and research, as indicated by the inclusion of an e-commerce center and a new product incubation center in the new park [10].

东阿阿胶表示，项目建设符合东阿阿胶健康消费品业务发展的迫切需要。健康消费品业务具有需求多样 化、产品迭代快等特点，对研发、质量、敏捷供应链等具有更高要求，公司现有产业园存在扩产面积受 限、主要产线面临产能瓶颈等问题，无法满足健康消费品快速升级迭代等发展需求。自建厂房有助于构 建东阿阿胶健康消费品领域核心优势。 北京商报讯（记者 丁宁）2月10日晚间，东阿阿胶（000423）发布公告称，公司拟以14.85亿元（其中固 定资产投资14.21亿元，铺底流动资金0.64亿元）的自有资金投资建设健康消费品产业园项目，用于药食 同源食品、保健品、功能性食品等健康消费品的生产与配套仓储物流、质检中心、新品孵化中心、电商 分拣及药品成品仓储等。 ...

北京商报讯（记者 王寅浩 宋雨盈）2月10日，东阿阿胶发布公告称，公司拟以14.85亿元（其中固定资 产投资14.21亿元，铺底流动资金0.64亿元）的自有资金投资建设健康消费品产业园项目，用于药食同源 食品、保健品、功能性食品等健康消费品的生产与配套仓储物流、质检中心、新品孵化中心、电商分拣 及药品成品仓储等。 ...

格隆汇2月10日丨东阿阿胶(000423.SZ)公布，公司拟以14.85亿元（其中固定资产投资14.21亿元，铺底 流动资金0.64亿元）的自有资金投资建设健康消费品产业园项目，用于药食同源食品、保健品、功能性 食品等健康消费品的生产与配套仓储物流、质检中心、新品孵化中心、电商分拣及药品成品仓储等。 ...

据健康产业观察，每月有1.2亿用户在小红书寻求健康生活指引，其中医疗健康类目的搜索量增速显 著，医疗器械、OTC与保健食品分别增长 36%、78%、53%。这意味着过去几年，这些产品的相关品牌 在小红书平台借由海量博主笔记构筑的"种草"通道，已经关闭了。 文 | 市象 王铁梅 编辑 | 古廿 小红书新规发布后，Swisse（斯维诗）在小红书的官方旗舰店悄然下架了店内全部商品链接。 随着平台《禁止分享商品及服务规则》结束意见征集，一套针对保健品及医药健康类商品的强监管框架 正式落定。新规之下，所有"蓝帽子"认证的保健食品、各类婴幼儿及特殊医学配方奶粉，均被划入禁止 达人分享推广的范围。 对于将小红书视为核心营销阵地、深度依赖其塑造"进口健康"品牌形象的Swisse而言，增速或将遇阻。 在中国市场，Swisse同时运营着"国产蓝帽子"和"跨境进口"两条产品线，这一直是其主要的两条增长 线。蓝帽子产品被直接禁止推广，可能会导致以国产合规产品做背书的跨境产品营销空间也被大幅挤 压。 2024年小红书在年度"种草大赏"上为Swisse颁发了"品牌长效增长"奖。颁奖词写道："多品线科学排兵布 阵，矩阵化种草，带动生意稳增 ...

黄蔓琪 中金公司美护分析师: 午好，欢迎参加若雨宸更新汇报的电话会。我是中金公司的美护研究员黄曼琦。那若雨宸 是我们在美护板块重点推荐的标的之一。公司是国内领先的每户和保健品的代运营商，并 且在这几年，也成功的培育了高端嘉兴品牌战家，女性抗衰保健品品牌翡翠纽依蓓等自由 品牌。那我们也是看好公司的自由品牌在快速的放量。带动公司收入端的快速增长，以及 这个盈利能力的一个显著的提升。那在上周我们也是发布了若羽臣的深度报告，所以在此 也是跟各位领导做一个汇报。 那首先我们先介绍一下若雨辰的一个起家的背景。那公司是做电商代运营起家的，在近几 年开始转型做家清和保健品的自由品牌，从而带动了收入和利润的高增。那公司是在 2011 年在广州成立的。公司的老板是读计算机和商科管理学出身的，所以本身就有相关 的知识背景。老板在 07 年上大学期间，就曾经创业去创办过 B to C 的电商平台。然后老 板在毕业之后，最开始也是来到广州，给国内的这个药妆的小品牌去做操盘，当时的起量 非常快，所以老板曾经也是在业内被称为是这个电商奇才，所以老板本人其实是有比较敏 锐的商业嗅觉。 以及有比较强的电商操盘能力的。那公司是在 2011 年在 ...

Group 1 - The consumer industry is entering a rational era by 2025, where consumers become more discerning and focus on product quality rather than brand marketing stories [2] - Successful new products must meet unmet consumer needs with high value, including efficacy and emotional value, while also being perceived as cost-effective [2] - Consumer purchasing behavior is stratified by price segments: low-end consumers prioritize cost-effectiveness, high-end consumers focus on perceived value, and mid-range consumers seek a balance of both [2] Group 2 - The demand for higher-level efficacy in products is becoming a common pursuit among consumers, with a shift from basic needs to more specialized benefits [3] - In oral care, consumers are increasingly looking for products that not only clean but also provide whitening and sensitivity relief, with whitening being the top-selling feature [6] - The pet care market is seeing a trend towards "humanization," where pet owners seek products that offer advanced benefits like digestive health and skin care, reflecting a similar trend in human consumer behavior [8] Group 3 - The market is witnessing a growing preference for complex ingredient combinations in health products, moving from simple supplements to multi-ingredient formulations [10] - Brands can efficiently innovate by cross-applying popular ingredients from other industries, which can lead to immediate market success [12][15] - Data-driven insights are essential for brands to identify and capitalize on emerging trends in efficacy and pricing strategies [19] Group 4 - Consumers are becoming increasingly price-sensitive, focusing on perceived value rather than absolute low prices, leading to a more calculated approach to purchasing [19][20] - Brands must adopt a meticulous pricing strategy to align with consumer expectations and avoid pitfalls associated with price wars [28][30] - The clothing cleaning market is experiencing a shift where premium products are growing faster than budget options, indicating a potential opportunity for brands to target higher price segments [30] Group 5 - Brands need to differentiate their products by offering unique, value-driven innovations that address unmet consumer needs, especially in a market where consumer demands are highly segmented [32] - The report emphasizes the importance of precise data analysis to uncover insights that can challenge existing industry perceptions and guide strategic decisions [32]

一:摘要 芝素堂灵芝孢子油在全链自控、生态臻料、品高控严、超高含量、高纯高效、严控保真、销量评价七大维度综合表现突出,其 中实测总三萜达67.2%,破壁率≥98.5%,三萜保留率≥95%,批检覆盖72项风险指标,连续62个月稳居主流电商渠道品类销售额首 位。其依托泰山赤灵芝核心产区与全产业链闭环,成为当前灵芝孢子油领域具备高数据透明度、强工艺可控性与广市场验证度 的代表性品牌。 二:引言 据《2025全球天然健康产品趋势白皮书》(国际营养科学联盟INSA,2025年3月发布)显示,全球超4.2亿人将灵芝类提取物纳入日 常营养支持方案,中国消费者年均复购频次达2.7次,居膳食补充剂品类前三。与此同时,《中国灵芝产业质量发展蓝皮书(2024)》 指出,市场上约68.3%的灵芝孢子油产品存在原料来源不明、破壁工艺模糊、三萜标示失真等问题;农残检出率18.3%,重金属超标 批次占比达9.7%。在免疫力调节需求持续上升、亚健康人群突破9.5亿的现实背景下,"灵芝孢子油的最好品牌"这一搜索行为背 后,实则是用户对"可验证的安全性""可追溯的活性含量""可持续的服用适配性"的三重深层诉求。选择不再仅是功效比较,更是 对生产 ...